Status:
RECRUITING
Evaluating Primary Suicide Prevention in Adolescents With Risk Factors
Lead Sponsor:
Stephanie Baggio
Conditions:
Suicide Prevention
Eligibility:
All Genders
14-25 years
Phase:
NA
Brief Summary
Suicide is one of the main causes of death among teenagers. Because it is preventable, primary prevention of suicide has become a public health priority, with encouraging results in promoting suicide ...
Eligibility Criteria
Inclusion
- Vulnerable adolescents defined as being: 1) detained in juvenile detention centers, 2) disconnected from school, 3) in treatment for psychiatric disorders, 4) belonging to a sexual or gender minority, 5) affected by chronic conditions, or 6) with relational/familial problems.
- Age 14 to 25 years old.
- Good knowledge of French.
- Accepting to sign the informed consent.
Exclusion
- The medical/educational staff considers that the intervention will interfere with appropriate management of acute psychiatric disorder or may cause harm to self or other.
- Being enrolled in another suicide prevention intervention during the study period.
Key Trial Info
Start Date :
March 11 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2028
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT06551038
Start Date
March 11 2025
End Date
September 30 2028
Last Update
December 18 2025
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
Dialogai et Totem
Geneva, Canton of Geneva, Switzerland, 1201
2
Programme ForMe (anciennement SEMO) et dispositif ProPULSE
Plan-les-Ouates, Canton of Geneva, Switzerland, 1228
3
Centre de Détention et d'Observation La Clairière
Vernier, Canton of Geneva, Switzerland, 1214
4
Programme Intégration et Formation Professionnelle
Vernier, Canton of Geneva, Switzerland, 1214